Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection

This JAMA Clinical Guidelines Synopsis summarizes the 2025 Infectious Diseases Society of America (IDSA) updated recommendations on antiviral treatment for mild to moderate COVID-19 in adults.

Authors

Kristen Marks (ORCID: https://orcid.org/0000-0003-1896-4978)
Peggy B. Leung
Andrew M. Davis

Institutions

Cornell University (US)
University of Chicago (US)
Weill Cornell Medicine (US)

Publication Details

Journal: JAMA
Published: 2026-06-30
DOI: https://doi.org/10.1001/jama.2026.6918
Primary Topic: COVID-19 Clinical Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection

Kristen Marks, Peggy B. Leung, Andrew M. Davis

Jun 30, 2026

JAMA

COVID-19 Clinical Research Studies

article

Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection

Kristen Marks, Peggy B. Leung, Andrew M. Davis

June 30, 2026article en

Abstract

This JAMA Clinical Guidelines Synopsis summarizes the 2025 Infectious Diseases Society of America (IDSA) updated recommendations on antiviral treatment for mild to moderate COVID-19 in adults.

JAMA

Cornell University (US), University of Chicago (US), Weill Cornell Medicine (US)

Good health and well-being

Openalex Percentile: Top 8%

COVID-19 Clinical Research Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.